HCA Healthcare (NYSE:HCA) Stock Rating Upgraded by Wall Street Zen

HCA Healthcare (NYSE:HCA) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

Other research analysts have also issued research reports about the company. Wells Fargo & Company boosted their price objective on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. The Goldman Sachs Group started coverage on shares of HCA Healthcare in a research report on Tuesday, October 14th. They set a “buy” rating and a $470.00 price objective on the stock. Truist Financial set a $460.00 target price on HCA Healthcare in a research note on Tuesday, October 14th. Bank of America upped their price objective on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Finally, Barclays lifted their price objective on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a report on Thursday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $437.19.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $446.58 on Friday. The company has a market cap of $104.50 billion, a price-to-earnings ratio of 17.26, a PEG ratio of 1.41 and a beta of 1.40. HCA Healthcare has a one year low of $289.98 and a one year high of $461.56. The firm has a fifty day moving average price of $414.84 and a two-hundred day moving average price of $382.33.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts expect that HCA Healthcare will post 24.98 EPS for the current fiscal year.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

Institutional Trading of HCA Healthcare

Several institutional investors have recently bought and sold shares of HCA. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare in the first quarter worth approximately $26,000. Saudi Central Bank bought a new position in HCA Healthcare in the 1st quarter valued at approximately $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare in the 1st quarter worth $27,000. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare during the second quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare in the 2nd quarter worth about $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.